Home > Boards > US OTC > Biotechs > Eyenovia, Inc. (EYEN)

Company is a conduit for drug delivery for

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jdlamont Member Profile
 
Followed By 2
Posts 763
Boards Moderated 0
Alias Born 08/10/11
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 4:12:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 4:12:42 PM
Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia GlobeNewswire Inc. - 6/4/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2019 5:26:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 5:20:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2019 4:23:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2019 6:54:16 AM
Eyenovia Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/14/2019 6:30:00 AM
Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRS-ASOA Annual Meeting GlobeNewswire Inc. - 5/6/2019 8:30:00 AM
Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/1/2019 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 8:36:49 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 8:32:40 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/27/2019 5:24:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2019 6:56:34 AM
Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire Inc. - 3/27/2019 6:30:00 AM
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire Inc. - 3/13/2019 8:30:00 AM
Eyenovia to Participate in Two Upcoming Investor Conferences GlobeNewswire Inc. - 3/4/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2019 8:46:34 AM
Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis GlobeNewswire Inc. - 2/25/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/19/2019 4:09:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2019 8:46:36 AM
Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering GlobeNewswire Inc. - 2/13/2019 8:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/13/2019 6:24:10 AM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 2/7/2019 4:45:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/6/2019 8:58:21 AM
jdlamont   Monday, 04/29/19 10:54:02 AM
Re: jdlamont post# 2
Post # of 5 
Company is a conduit for drug delivery for every topical eye care drug company in existence, and hence will be bought out.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2019 InvestorsHub.com, Inc.